RECRUITING

Assessing Claims of Cannabis as an Anti-cancer Agent (CATA)

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of the study is to find out how cannabis may help control cancer growth by reviewing medical records of patients who report cannabis helped treat their cancer.

Official Title

Cannabis as an Anti-cancer Agent: A Review of Medical Records in Patients With Cancer to Assess Potential Anti-cancer Benefits From Using Cannabis

Quick Facts

Study Start:2021-03-19
Study Completion:2027-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT07107607

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:Not specified
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:CHILD, ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * diagnosed with cancer
  2. * have used any type of cannabis/marijuana, including those with cannabidiol (CBD) and/or tetrahydrocannabinol (THC) to treat their cancer
  3. * believe that cannabis has either stopped the tumor from growing and/or caused a cancer antigen blood marker to remain stable or cannabis has shrunken the tumor and/or caused reduction in a cancer antigen blood marker
  1. * does not have cancer
  2. * has not used any type of cannabis/marijuana, including those with CBD and/or THC to treat their cancer
  3. * does not believe that cannabis has either stopped the tumor from growing and/or caused a cancer antigen blood marker to remain stable or cannabis has shrunken the tumor and/or caused reduction in a cancer antigen blood marker

Contacts and Locations

Study Contact

Jordan Cowger, MPH
CONTACT
952-993-6071
jordan.cowger@parknicollet.com

Study Locations (Sites)

HealthPartners Institute Cancer Research Center
Saint Louis Park, Minnesota, 55426
United States

Collaborators and Investigators

Sponsor: HealthPartners Institute

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-03-19
Study Completion Date2027-01

Study Record Updates

Study Start Date2021-03-19
Study Completion Date2027-01

Terms related to this study

Keywords Provided by Researchers

  • cancer
  • cannabis
  • marijuana
  • tetrahydrocannabinol
  • cannabidiol

Additional Relevant MeSH Terms

  • Cancer
  • Cancer (With or Without Metastasis)